Publicaciones en colaboración con investigadores/as de Fundación Jiménez Díaz (18)

2023

  1. Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2

    Viruses, Vol. 15, Núm. 7

2022

  1. Discovering HIV related information by means of association rules and machine learning

    Scientific Reports, Vol. 12, Núm. 1

  2. Viruses and Mycoplasma pneumoniae are the main etiological agents of community-acquired pneumonia in hospitalized pediatric patients in Spain

    Pediatric pulmonology, Vol. 57, Núm. 1, pp. 253-263

2021

  1. Exploiting the Microbiota for the Diagnosis of Anal Precancerous Lesions in Men Who Have Sex with Men

    Journal of Infectious Diseases, Vol. 224, Núm. 7, pp. 1247-1256

2020

  1. Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: A multicentre cohort study

    AIDS Research and Therapy, Vol. 17, Núm. 1

  2. Recommendations for the early diagnosis of suspected human immunodeficiency virus infection in the emergency department and the referral of patients for follow-up: A consensus statement of the spanish society of emergency medicine (semes)

    Emergencias, Vol. 32, Núm. 6, pp. 416-426

2019

  1. Choice of the initial antiretroviral treatment for HIV-positive individuals in the era of integrase inhibitors

    PLoS ONE, Vol. 14, Núm. 8

  2. Durability of first-line antiretroviral regimens in the era of integrase inhibitors: A cohort of HIV-positive individuals in Spain, 2014-2015

    Antiviral Therapy, Vol. 24, Núm. 3, pp. 167-175

  3. Effects of immunonutrition in advanced human immunodeficiency virus disease: A randomized placebo-controlled clinical trial (Promaltia study)

    Clinical Infectious Diseases, Vol. 68, Núm. 1, pp. 120-130

  4. Lower expression of plasma-derived exosome miR-21 levels in HIV-1 elite controllers with decreasing CD4 T cell count

    Journal of Microbiology, Immunology and Infection, Vol. 52, Núm. 4, pp. 667-671

2018

  1. Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients

    Medicine (United States), Vol. 97, Núm. 38

  2. Low-level viremia is associated with clinical progression in HIV-infected patients receiving antiretroviral treatment

    Journal of Acquired Immune Deficiency Syndromes, Vol. 78, Núm. 3, pp. 329-337

2014

  1. A low-cost, sustainable, second generation system for surveillance of people living with HIV in Spain: 10-year trends in behavioural and clinical indicators, 2002 to 2011

    Eurosurveillance, Vol. 19, Núm. 20

  2. HIV-2 and HTLV-1 infections in Spain, a non-endemic region

    AIDS Reviews, Vol. 16, Núm. 3, pp. 152-159

  3. HIV-2 viral tropism influences CD4+ T cell count regardless of viral load

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 8, pp. 2191-2194

2010

  1. Documento de consenso sobre diagnóstico, tratamiento y prevención de la tuberculosis

    Archivos de Bronconeumologia, Vol. 46, Núm. 5, pp. 255-274

2008

  1. Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of hiv type 1 infection: Final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903

    Clinical Infectious Diseases, Vol. 47, Núm. 8, pp. 1083-1092

2004

  1. Improvement of dyslipidemia in patients switching from stavudine to tenofovir: Preliminary results

    AIDS, Vol. 18, Núm. 10, pp. 1475-1478